Genetic Information Nondiscrimination Act

Genetic Information Nondiscrimination Act
The Genetic Information Nondiscrimination Act (GINA) is a United States federal law that prohibits discrimination in health coverage and employment based on genetic information. Enacted in 2008, GINA aims to protect individuals from being treated unfairly due to their genetic makeup.
Background[edit]
Genetic information refers to data about an individual's genetic tests, genetic tests of family members, and the manifestation of a disease or disorder in family members. Prior to the passage of GINA, concerns arose that individuals might avoid genetic testing or counseling out of fear that the information could be used against them in health insurance or employment decisions.
Provisions[edit]
Under GINA, health insurers are prohibited from using genetic information to deny coverage, adjust premiums, or impose preexisting condition exclusions. Similarly, employers are restricted from using genetic information in hiring, firing, or promotion decisions. GINA also prohibits the collection of genetic information by employers except in limited circumstances.
Enforcement[edit]
The Equal Employment Opportunity Commission (EEOC) enforces GINA's employment provisions, while the Department of Health and Human Services oversees compliance with the law in the health insurance sector. Individuals who believe their rights under GINA have been violated can file complaints with these agencies.
Impact[edit]
Since its enactment, GINA has provided important protections for individuals seeking genetic testing and counseling. By safeguarding against discrimination, the law has encouraged more people to take advantage of genetic services without fear of negative repercussions.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian